Literature DB >> 11266782

Transplantation and the CD28/CTLA4/B7 pathway.

M Alegre1, F Fallarino, P Zhou, K Frauwirth, J Thistlethwaite, K Newell, T Gajewski, J Bluestone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11266782     DOI： 10.1016/s0041-1345(00)01977-1

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Allogenic donor splenocytes pretreated with antisense peptide against B7 prolong cardiac allograft survival.

Authors:  J Chen; Q He; R Zhang; Y Chu; Y Wang; Q Liu; S Xiong
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

Review 2.  Concise review: immunologic lessons from solid organ transplantation for stem cell-based therapies.

Authors:  Andrea Loewendorf; Marie Csete
Journal:  Stem Cells Transl Med       Date:  2013-01-24       Impact factor: 6.940

3.  CD28, costimulator or agonist receptor?

Authors:  David H Margulies
Journal:  J Exp Med       Date:  2003-04-21       Impact factor: 14.307

4.  TCR and CD28 activate the transcription factor NF-κB in T-cells via distinct adaptor signaling complexes.

Authors:  Youg Raj Thaker; Helga Schneider; Christopher E Rudd
Journal:  Immunol Lett       Date:  2014-10-23       Impact factor: 3.685

5.  Glycogen Synthase Kinase 3 Inactivation Compensates for the Lack of CD28 in the Priming of CD8+ Cytotoxic T-Cells: Implications for anti-PD-1 Immunotherapy.

Authors:  Alison Taylor; Christopher E Rudd
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.